Lilly(Eli) & Co

LLY

$243.06

+22.6% last 12 months

Market Cap

$233 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$176.65 - $283.90

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

38.94x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$3.38 (1.39%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $233 Billion
Enterprise Value $246 Billion
Dividend Yield $3.38 (1.39%)
1 Year Return +24.0%
52-Week High $283.90
52-Week Low $176.65
Beta 0.61
Outstanding Shares 957 Million
Avg 30 Day Volume 2.55 Million

Valuation

P/E Ratio 38.94
PEG -478.71
Earnings per Share $6.55
Price to Sales Ratio 8.38
Price to Book Ratio 30.38
Revenue to Enterprise Value 8.86
EBIT to Enterprise Value 32.87
Total Debt to Enterprise Value 0.07
Debt to Equity 2.2

Profitability

Revenue $27.8 Billion
Gross Profit $20.8 Billion
EBIT $7.48 Billion
Net Income $5.97 Billion
Profit Margin 21.52%
Quarterly Earnings Growth (YoY) -8.1%
Return on Equity 76.99%
Return on Assets 12.39%
Return on Invested Capital 21.67%

Insider trades

546 shares bought (1 transactions)

240,414 shares sold (8 transactions)

No purchases

381,508 shares sold (14 transactions)

No purchases

168,247 shares sold (7 transactions)

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Lilly(Eli) & Co

CEO: David Ricks

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Merck & Co Inc
Merck & Co Inc
Johnson & Johnson
Johnson & Johnson
Pfizer Inc.
Pfizer Inc.
Sanofi - ADR
Sanofi - ADR
Glaxosmithkline plc - ADR
Glaxosmithkline plc - ADR
Abbvie Inc
Abbvie Inc
AMGEN Inc.
AMGEN Inc.
Novartis AG - ADR
Novartis AG - ADR
Astrazeneca plc - ADR
Astrazeneca plc - ADR

News